市場調查報告書
商品編碼
1423182
2024-2032 年按產品、解決方案、應用、組件、部署和地區分類的 3D 醫學影像設備市場報告3D Medical Imaging Equipment Market Report by Product, Solution, Application, Component, Deployment, and Region 2024-2032 |
2023年全球3D醫學影像設備市場規模達到131億美元。展望未來, IMARC Group預計到2032年市場規模將達到197億美元,2024-2032年複合年成長率(CAGR)為4.5%。
醫學影像是一種創建體內內部器官的視覺描述的技術,用於疾病的臨床診斷及其後續的醫療。 3D 影像技術可幫助醫療保健專業人員捕捉多個角度的影像並顯示不同深度的組織,同時增強解析度和更複雜的細節,以便更好地了解人體。與先前使用的可能產生錯誤結果的成像技術不同,3D 成像技術可以在診斷任何醫療疾病時提供精確的資訊。事實證明,它在各種醫學疾病的診斷中具有革命性的意義,其中包括對乳癌治療至關重要的數位乳房斷層合成 (DBT)
蓬勃發展的醫療保健產業是推動市場成長的關鍵因素之一。由於久坐的生活方式和老年人口的顯著增加,生活方式疾病和與年齡相關的疾病的發生率均增加。因此,這增加了醫療保健領域對 3D 醫學影像設備的需求。此外,技術的進步,加上人們對該技術的好處的認知不斷提高,例如內臟器官的準確視覺表示、對周圍組織的損傷減少以及各種醫學成像程序提供的資料的準確性,刺激了市場的成長。全球各國政府不斷增加的醫療保健預算撥款和研發 (R&D) 活動進一步推動了市場的發展。
The global 3D medical imaging equipment market size reached US$ 13.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
Medical imaging is a technique of creating visual depictions of internal organs in the body for the clinical diagnosis of an ailment and its subsequent medical treatment. The 3D imaging technology has aided healthcare professionals to capture images at multiple angles and display tissues at varying depths along with enhanced resolutions and more intricate details to provide a better understanding of the human body. Unlike previously used imaging technologies which had possibilities of erroneous results, the 3D imaging technology offers precise information during the diagnosis of any medical ailment. It has proved revolutionary in the diagnosis of various medical illnesses, including digital breast tomosynthesis (DBT), which is crucial in the treatment of breast cancer
The thriving healthcare industry is one of the key factors driving market growth. There has been a rise in the occurrence of lifestyle diseases along with age-related ailments owing to sedentary lifestyles and a significant increase in the geriatric population, respectively. This has consequently bolstered the demand for 3D medical imaging equipment in the healthcare sector. Moreover, technological advancements coupled with the rising awareness about the benefits of this technology such as an accurate visual representation of internal organs, reduced damage to surrounding tissues and accuracy of data offered by various medical imaging procedures has stimulated the market growth. The market is further driven by increasing healthcare budgetary allocations and research and development (R&D) activities by governments of various nations across the globe.
IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D medical imaging equipment market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product, solution, application, component and deployment.
X-Ray
Ultrasound
MRI
CT Scan
Hybrid Imaging
3D Scanning
3D Rendering
3D Modeling
Oncology
Cardiology
Orthopedics
Others
Hardware
Software
Service
On-Premise Based Platform
Cloud Based Platform
Web Based Platform
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being GE Healthcare, Philips Electronics Nederland B.V., Siemens Healthineers, FUJIFILM Corporation, Analogic Corporation, ContextVision AB, Dentsply Sirona, EOS imaging, Esaote S.p.A, Fuel 3D Technologies Limited, KaVo Dental GmbH, Hologic, Inc., Intelerad Medical Systems, Planmeca Group, Samsung Medison and Shimadzu Corporation.
IMARC Group's latest report provides a deep insight into the global 3D medical imaging equipment market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global 3D medical imaging equipment market in any manner.